All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your GvHD Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

AML Hub

AML Hub

Lupus Hub

Lupus Hub

Lymphoma Hub

Lymphoma Hub

MPN Hub

MPN Hub

Multiple Myeloma

Multiple Myeloma Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact

Brought to you by

Scientific Education Support logo

The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

TypesTherapeuticsCongressesTrialsExpert OpinionsEducational ResourcesDRUG UPDATES
2021-04-07T11:49:08.000Z

How can CMV infection increase the risk of chronic GvHD?

By Paola Frisone, Georgia Scurfield, Maria Kasimati
Featured
Katrine Kielsen
Apr 7, 2021
Share:

Bookmark this article

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Katrine Kielsen, Rigshospitalet, Copenhagen, DK. We asked, How can CMV infection increase the risk of chronic GvHD?

How can CMV infection increase the risk of chronic GvHD?

Kielsen discusses the results from a study reported at EBMT 2021, showing that cytomegalovirus (CMV)-associated thymus dysfunction leads to an increased risk of chronic GvHD development.

 

More about...
Chronic graft-versus-host diseaseEBMT 2021InfectionRisk

Your opinion matters

HCPs, what is your preferred format for educational content on the GvHD Hub?
8 votes - 27 days left ...

Related articles

Add bookmark

Impact of Clostridioides difficile infection and its treatment on allo-HSCT outcomes

Here, we summarize an article by Piekarska et al. evaluating the impact of effective treatment of Clostridioides difficile infection on allo-HSCT outcomes, including...

Apr 29, 2024
Add bookmark

Impact of Clostridioides difficile infection and its treatment on allo-HSCT outcomes

Here, we summarize an article by Piekarska et al. evaluating the impact of effective treatment of Clostridioides...

Apr 29, 2024
Add bookmark

Impact of fungal infections on transplant outcomes: A CIBMTR analysis

Here, we summarize key findings from a CIBMTR analysis by Papanicolaou et al.1 examining the impact of fungal infections on transplant outcomes with PTCy-based GvHD prophylaxis.

Nov 23, 2023
Add bookmark

Impact of fungal infections on transplant outcomes: A CIBMTR analysis

Here, we summarize key findings from a CIBMTR analysis by Papanicolaou et al.1 examining the impact of fungal infections on...

Nov 23, 2023
Add bookmark

The role of clostridium difficile infection in gastrointestinal graft-versus-host disease

The relationship between clostridium difficile infection (CDI) and acute gastrointestinal graft-versus-host disease (GI GvHD) in patients undergoing allogeneic...

Jul 30, 2018
Add bookmark

The role of clostridium difficile infection in gastrointestinal graft-versus-host disease

The relationship between clostridium difficile infection (CDI) and acute gastrointestinal graft-versus-host...

Jul 30, 2018
Add bookmark

Gastrointestinal graft-versus-host disease increases the risk of post-engraftment bloodstream infections

A retrospective study to evaluate the etiology, morbidity, outcomes, and risk factors of bloodstream infection (BSI) in patients undergoing...

Jul 13, 2018
Add bookmark

Gastrointestinal graft-versus-host disease increases the risk of post-engraftment bloodstream infections

A retrospective study to evaluate the etiology, morbidity, outcomes, and risk factors of...

Jul 13, 2018

Newsletter

Subscribe to get the best content related to GvHD delivered to your inbox